Case | Sex /Age(d) | Weight(kg)/Gestation (weeks) | Country | Treatment | Course | Year of publication [Reference] |
---|---|---|---|---|---|---|
1 | F/4 | 2.2/35 | ZAF | Rifampicin + Ampicillin | Death | 1978 [4] |
2 | F/1.5 | 3.7/ND | USA | Ampicillin + Gentamicin | Death | 1980 [5] |
3 | M/2 | 3.5/41 | NA | Penicillin + Gentamicin | Survived | 1981 [6] |
4 | M/4 | 2.8/39 | NA | Ampicillin + Gentamicin | Death | 1982 [7] |
5 | M/2 | 3.3/43 | USA | Ampicillin + Kanamycin | Death | 1983 [8] |
6 | M/1.5 | 4.0/ND | USA | Cefotaxime | Survived | 1988 [9] |
7 | M/2 | 2.4/34 | BEL | Ampicillin + Netilmicin→ | Death | 1989 [10] |
Ampicillin + Cefotaxime | ||||||
8 | M/4 | ND/37 | GER | Mezlocillin + Netilmicin + Cefotaxime→ Gentamicin + Cefotaxime | Death | 1992 [11] |
9 | F/3 | 3.4/40 | JPN | Cefotaxime | Survived | 1994 [12] |
10 | M/1 | 3.4/36 | CAN | Ampicillin + Gentamicin→ | Survived | 1996 [13] |
Cefotaxime + Gentamicin | ||||||
11 | ND/10 | ND/ND | CUB | Ampicillin + Gentamicin | Death | 1999 [14] |
12 | F/2 | 2.8/ND | TUR | Cefotaxime + Amikacin→ | Survived | 2010 [15] |
Meropenem |